Trending Alert: La Quinta Holdings Inc (NYSE:LQ), Ionis Pharmaceuticals Inc (NASDAQ:IONS)

On Monday, Shares of La Quinta Holdings Inc (NYSE:LQ), added 2.21% and closed at $11.09 in the last trading session. The last trading range of the stock ranges between $10.93 and $11.30. La Quinta Holdings Inc. (“La Quinta” or the “Company”) (LQ) recently stated its third quarter 2016 results, for the period ending September 30, 2016.

Third Quarter 2016 Highlights

Net Income per Share was $0.20; Adjusted Earnings per Share was $0.19

Net Income was $22.7 million; Adjusted Net Income was $22.1 million

Cash flow generation remained strong, as demonstrated by $100.7 million of Total Adjusted EBITDA

Grew franchise and other fee based revenue 5.3 percent

System-wide comparable RevPAR raised 0.8 percent, and apart from properties located in STR-defined “oil tracts”, RevPAR raised 2.0 percent

Opened 15 franchised hotels, apart from six temporary hotels, totaling about 1,300 rooms, counting the Company’s first location in Colombia, South America

Raised franchise pipeline to 239 hotels, representing about 21,800 additional rooms, counting a new franchise agreement in San Diego’s Gaslamp District

La Quinta Returns® ranked in the top 5 by U.S. News and World Report as a Best Travel Rewards program in U.S. News’s Best Travel Rewards 2016-17 rankings

Ionis Pharmaceuticals Inc (NASDAQ:IONS), jumped 11.56% and closed at $47.49 in the last trading session. The last trading range of the stock ranges between $42.77 and $48.24. The company’s Market capitalization is $5.97 Billion with the total Outstanding Shares of 121.20 million. Ionis Pharmaceuticals, Inc. (IONS) recently stated income from operations of $16.1 million and a loss from operations of $87.5 million for the three and nine months ended September 30, 2016, respectively.  The Company also stated pro forma operating income of $33.7 million and a pro forma net operating loss (NOL) of $30.5 million, both apart from non-cash stock compensation, for the same periods.  Ionis ended the third quarter with cash, cash equivalents and short term investments of $687.8 million.  The Company is on track to meet its pro forma NOL and cash guidance for the year.

Leave a Reply

Your email address will not be published. Required fields are marked *